Emergent BioSolutions, Inc. announced that effective as of January 4, 2016, Barry Labinger, the former Executive Vice President and President of the company's biosciences division, resigned from the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.93 USD | +5.17% | +16.28% | +230.42% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+230.42% | 395M | |
+56.89% | 809B | |
+39.52% | 624B | |
-6.55% | 351B | |
+7.92% | 289B | |
+13.74% | 240B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 166B | |
-2.57% | 157B |
- Stock Market
- Equities
- EBS Stock
- News Emergent BioSolutions Inc.
- Barry Labinger Resigns as Executive Vice President and President of Emergent BioSolutions, Inc.'s Biosciences Division